tumor therapy (Migragen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nametumor therapy (Migragen)
Drug Alias NameMigratoxin-1 (Migragen)Migratoxin-2 (Migragen)Migratoxins (Migragen)glioblastoma therapy (Migragen)
ClassificationBiologics > Protein drugs > Toxin
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGliomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMigragen AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMigragen AG
Active IndicationsN/A
Inactive IndicationsGliomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A